AKT1 and hepatocellular carcinoma: Likewise, miR-17-5p activates β1 integrin/PTEN/PI3K/Akt/matrix metalloproteinases (MMPs) pathway under increased stiffness in HCC cells and promotes matrix stiffness-induced resistance to metformin [84].